Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving treatment for patients with borderline personality disorder

Official title: PEGASUS - Improving Treatment for Patients With Emotionally Unstable Personality Disorder

Run by University Hospital Bispebjerg and Frederiksberg · NCT06563466 · Data updated 2026-11-12

This study is testing a new treatment approach for people with borderline personality disorder to see if adding case management and family meetings helps them feel better compared to standard care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital Bispebjerg and Frederiksberg
Academic / other
Locations1 site (Copenhagen)
StatusRecruiting
StartedSeptember 1, 2024
Main results expectedOctober 31, 2027
Study endsAugust 31, 2029
Registry record updatedApril 28, 2026
Trial IDNCT06563466 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are newly accepted into BPD treatment packages and can involve family members or close friends.

Probably not a fit

Patients with a primary diagnosis of schizophrenia or those with substance abuse issues may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The PEGASUS intervention aims to enhance treatment for individuals with emotionally unstable personality disorder, specifically borderline personality disorder, by integrating case management and family-based meetings into existing psychiatric care models in Denmark. This pilot trial will compare the PEGASUS intervention to standard treatment, assessing feasibility and acceptability through a randomized, assessor-blinded parallel-groups design. Participants will be evaluated at baseline and again nine months later to determine the effectiveness of the intervention in improving patient outcomes.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the quality of life and treatment outcomes for patients with borderline personality disorder.

How similar studies have gone: Previous studies have shown promise in integrating family involvement in the treatment of borderline personality disorder, suggesting that this approach may be beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Participating Patients

Inclusion Criteria:

* Must be able to give an informed written consent.
* Must be newly accepted in the pre-planned BPD treatment packages.
* ≥18 years of age.
* Agreeing to involvement of one or two informal caregivers, families, or close friends ("Relatives").
* Capable of reading and understanding Danish.

Exclusion Criteria:

* None\*

  * Note that to get accepted into a treatment package for BPD, patients must not fulfill the criteria for a F20 diagnosis or the criteria for alcohol or substance abuse or harmful use.

Participating Relatives:

Inclusion Criteria:

* Must be able to give an informed written consent.
* ≥18 years of age.
* Capable of reading and understanding Danish.

Exclusion criteria: None

Where it's running

  • Copenhagen Research Center for Mental Health - CORE
    Copenhagen, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.